Company News for Jun 30, 2020

Zacks Equity Research Published on June 30, 2020

Shares of Kiniksa Pharmaceuticals, Ltd. (KNSA - Free Report) jumped 12.9% after the company announced that the phase 3 trial of Rilonacept showed statistically significant results.
Shares of Tiziana Life Sciences PLC rose 12.8% after the company reported an agreement with STC Biologics for GMP manufacturing of an anti-interleukin-6-receptor monoclonal antibody used for clinical studies in COVID-19 patients.
Shares of Coty Inc. (COTY - Free Report) soared 13.4% after the company announced agreed to buy 20% stake in Kim Kardashian West's Make-up Brand for $200 million.
Shares of Intercept Pharmaceuticals, Inc. plunged 39.7% after the FDA stated concerns about effectiveness of the company's fibrosis treatment.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.